Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Xiaogang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1227-9243; OpenAlex author ID A5100355340. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper

Papers 5

  1. Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway. Co-author DOI 10.1016/j.omto.2020.03.006↗
  2. Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathw… Co-author DOI 10.1016/j.canlet.2018.05.043↗
  3. Impact of age on survival of patients with pancreatic cancer after surgery: Analysis of SEER data. Co-author DOI 10.1016/j.pan.2017.11.008↗
  4. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis. Co-author DOI 10.1038/s41598-017-06207-x↗
  5. miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. Co-author DOI 10.1093/carcin/bgv027↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shanmiao Gou · 4 shared papers, 2017–2020 · strength 0.42
  2. Zhiqiang Liu · 4 shared papers, 2017–2020 · strength 0.42
  3. Chunyou Wang · 3 shared papers, 2017–2018 · strength 0.29
  4. Ye Zeng · 2 shared papers, 2018 · strength 0.20
  5. Jingyuan Zhao · 1 shared paper, 2020 · strength 0.13
  6. Shihong Wu · 1 shared paper, 2020 · strength 0.13
  7. Heshui Wu · 1 shared paper, 2020 · strength 0.13
  8. Y. Zou · 1 shared paper, 2015 · strength 0.05
  9. J. Chen · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.